The standard treatment paradigm for muscle invasive bladder cancer has been neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy. However, efforts are ongoing to personalize ...

Efficacy and safety of disitamab vedotin (RC48) combined with toripalimab as adjuvant therapy after radical surgery for patients with HER2-overexpression upper tract urothelial cancer (UTUC): A single ...

Please provide your email address to receive an email when new articles are posted on . Creation Healthcare analyzed 1,462 English language posts on X by 1,050 health care professionals. Health care ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus pembrolizumab therapy." First authors Elias Antoine Karam of the Gustave Roussy and ...

Roughly 30% of patients with metastatic prostate cancer and 32% of those with advanced urothelial cancer underwent next-generation sequencing. Most patients with advanced prostate cancer or urothelial ...

Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...

They further applied two-sample Mendelian randomization (TSMR) analysis to examine genetic associations between prostate cancer and ten common secondary primary malignancies (SPMs). The study not only ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well as for friends and family who don’t really know what the diagnosis means. It ...

Mr Lim continued running and training for marathons after he was diagnosed with Stage 4 urothelial cancer in 2024.